Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
656 ELI-002 immunotherapy induces broad polyfunctional T cell responses in subjects with high relapse risk KRAS mutated pancreatic ductal adenocarcinoma and colorectal cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.